Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Anticoagulant Drugs Market & Antithrombotic Drugs Industry Analysis in New Research Reports


News provided by

RnRMarketResearch

20 Nov, 2012, 10:45 GMT

Share this article

Share toX

Share this article

Share toX

DALLAS, November 20, 2012 /PRNewswire/ --

- RnRMarketResearch.com adds new market research reports "Antithrombotic / Anticoagulant Drugs: Technologies and Global Markets" to its store.

This report provides an overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals. Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 as well as breakdowns of the market size of anticoagulants by revenue at manufacturers' sales levels, including low molecular weight heparins and oral anticoagulants, as well as breakdowns of antiplatelets and thrombin inhibitors are covered. The research also has a discussion of research and development of antithrombotic/anticoagulant treatments and comprehensive company profiles of top leaders in each of the market segments along with companies that are novel or have specific interest to the field.

This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs market for various cardiovascular applications.  The geographic scope of the report is global with a special emphasis on individual regions such as the United States, Europe, Japan and Rest of World.  The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.

Categories discussed in the report include:

  • Anticoagulants
  • Antiplatelets
  • Thrombin inhibitors

All categories are discussed in detail, describing each segment, identifying current products on the market, measuring market size, identifying market drivers, forecasting for 2012 to 2017 and assessing the competitors and competitor market shares.

Buy your copy of this report @ http://www.rnrmarketresearch.com/antithrombotic-anticoagulant-drugs-technologies-global-markets-market-report.html.

This study is presented to increase the awareness of antithrombotic/ anticoagulant drugs to treat thrombotic disease and other diseases that are linked to thrombotic disease.  The study analyzes (1) select antithrombotic/anticoagulant drugs for treating various thrombotic diseases in coronary artery disease, peripheral vascular disease, valvular heart disease, congestive heart failure and many others; (2) the marketing of these drugs in the global market from different standpoints; and (3) the issues and trends affecting the market.

Antithrombotic/anticoagulant manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of products.  Because of the evolving nature of this important area of study, executives of product development for antithrombotic/anticoagulant drugs must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of the market.

Table of Contents for the report "Antithrombotic / Anticoagulant Drugs: Technologies and Global Markets" cover:

Chapter- 1: Introduction
Study Goals And Objectives
Reasons For Study
Scope Of Study
Methodology And Information Sources
Analyst Credentials
Related Bcc Reports
Bcc On-Line Services
Disclaimer
Chapter- 2: Executive Summary
Table Summary : Total Global Market Size And Growth By Region For Anticoagulant Drugs, Through 2017
Figure Summary : Total Global Market Size And Growth By Region For Anticoagulant Drugs, 2011-2017
Chapter- 3: Industry Overview
The Circulatory System
Conditions
Hemostasis (The Clotting Process)
Diseases Associated With Thromboembolism
Stents And Thrombosis
Demographics
Venous Thromboembolism And Lifestyle
Venous Thromboembolism And Air Travel
Chapter- 4: Anticoagulants
Overview
Products
Global Market Size And Growth
Growth By Geographic Region
Growth By Drug Type
Competitive Analysis
Chapter- 5: Antiplatelets
Overview
Products
Global Market Size And Growth
Growth By Geographic Region
Growth By Drug Type
Chapter- 6: Thrombin Inhibitors
Overview
Products
Global Thrombin Inhibitor Market Size And Growth
Thrombin Inhibitor Growth By Geographic Region
Growth By Drug Type
Competitive Analysis
Research And Development
Total Market Analysis
Chapter- 7:Company Profiles
Abbott Laboratories
Armetheon Inc.
Astrazeneca
Baxter International
Bayer Ag
Biovascular, Inc.
Boehringer Ingelheim Gmbh
Bristol-Myers Squibb Company
Canyon Pharmaceuticals
Cornerstone Therapeutics, Inc.
Csl Behring
Daiichi Sankyo Company Ltd
Eisai Company, Ltd.
Eli Lilly
Emisphere Technologies
Genentech
Glaxosmithkline
Gtc Biotherapeutics
Johnson & Johnson
Ligand Pharmaceuticals, Inc.
Merck
Merrion Pharmaceuticals, Ltd.
Microbix Biosystems, Inc.
Novartis
Ono Pharmaceutical Co., Ltd
Otsuka Pharmaceutical Co., Ltd.
Pfizer, Inc
Portola Pharmaceuticals
Regado
Sanofi
Santa Cruz Biotechnology, Inc.
Servier
The Medicines Company
Chapter- 8: A Complete Listing Of All The Companies In The Report
List Of Tables
Summary Table : Total Global Market Size And Growth By Region For Anticoagulant Drugs, Through 2017
Table 1 : Factors Predisposing To Pulmonary Embolism Of Virchow's Triad
Table 2 : Total Global Population By Selected Geographical Region, 2000 To 2050
Table 3 : Heart Disease Deaths By Country
Table 4 : U.S. Stroke Demographics By Selected Characteristics, 2010
Table 5 : Global Market Size And Growth By Region For Anticoagulant Drugs, Through 2017
Table 6 : Global Market For Anticoagulant Drug Revenues By Region, 2012
Table 7 : Forecast Global Market For Anticoagulant Drug Revenues By Region, 2017
Table 8 : Global Market Size Of Anticoagulant Drug Revenues By Drug Type, Through 2017
Table 9 : Global Anticoagulant Drug Market By Drug Type, 2012
Table 10 : Global Anticoagulant Drug By Drug Type, 2017
Table 11 : Total Global Anticoagulant Drug Market Competitive Analysis, 2012
Table 12 : Total Global Anticoagulant Drug Manufacturer Product Participation By Drug Type
Table 13 : Total Global Market Size And Growth By Region For Antiplatelet Drugs, Through 2017
Table 14 : Total Global Market For Antiplatelet Drug Revenues By Region, 2012
Table 15 : Forecast Global Market For Antiplatelet Drug Revenues By Region, 2017
Table 16 : Global Market Size Of Antiplatelet Drug Revenue By Drug Type, Through 2017
Table 17 : Global Antiplatelet Drug Market By Drug Type, 2012
Table 18 : Global Antiplatelet Market By Drug Type, 2017
Table 19 : Total Global Antiplatelet Drug Market Competitive Analysis, 2012
Table 20 : Global Antiplatelet Drug Manufacturer Product Participation By Drug Type
Table 21 : Projected Global Market Size And Growth By Region For Thrombin Inhibitors, Through 2017
Table 22 : Total Global Market For Thrombin Inhibitor Drug Revenues By Region, 2012
Table 23 : Total Global Market For Thrombin Inhibitor Drug Revenues By Region, 2017
Table 24 : Global Thrombin Inhibitor Market Revenue By Drug Type, Through 2017
Table 25 : Global Thrombin Inhibitor Market By Drug Type, 2012
Table 26 : Global Thrombin Inhibitor Market By Drug Type, 2017
Table 27 : Total Global Thrombin Inhibitor Drug Market Competitive Analysis, 2012
Table 28 : Total Global Thrombin Inhibitor Drug Manufacturer Product Participation By Drug Type
Table 29 : Antithrombotic/Anticoagulant Treatments In Development, 2012
Table 30 : Size Of Global Antithrombotic/Anticoagulant Market Revenue By Drug Type, Through 2017
Table 31 : Global Antithrombin/Anticoagulant Market By Drug Type, 2012
Table 32 : Forecast Global Antithrombin/Anticoagulant Market By Drug Type 2017
Table 33 : Global Market Size And Growth By Region For Antithrombotic/Anticoagulant Drugs, Through 2017
Table 34 : Global Antithrombotic/Anticoagulant Market By Geographic Region, 2012
Table 35 : Global Antithrombotic/Anticoagulant By Geographic Region, 2017
Table 36 : Global Antithrombin/Anticoagulant Drug Market Competitive Analysis, 2012
Table 37 : Global Antithrombotic/Anticoagulant Manufacturer Product Participation By Drug Type
List Of Figures
Summary Figure : Total Global Market Size And Growth By Region For Anticoagulant Drugs, 2011-2017
Figure Sample Figure : Total Global Market Size And Growth By Region For Anticoagulant Drugs, 2011-2017
Figure 1 : Total Global Population By Selected Geographical Region, 2000 To 2050
Figure 2 : Global Market Size And Growth By Region For Anticoagulant Drugs, 2011-2017
Figure 3 : Global Market For Anticoagulant Drug Revenues By Region, 2012
Figure 4 : Forecast Global Market For Anticoagulant Drug Revenues By Region, 2017
Figure 5 : Global Market Size Of Anticoagulant Drug Revenue By Drug Type, 2011-2017
Figure 6 : Global Anticoagulant Drug Market By Drug Type, 2012
Figure 7 : Global Anticoagulant Market By Drug Type, 2017
Figure 8 : Total Global Anticoagulant Drug Market Competitive Analysis, 2012
Figure 9 : Total Global Market Size And Growth By Region For Antiplatelet Drugs, 2011-2017
Figure 10 : Total Global Market For Antiplatelet Drug Revenues By Region, 2012
Figure 11 : Forecast Global Market For Antiplatelet Drug Revenues By Region, 2017
Figure 12 : Global Market Size Of Antiplatelet Drug Revenue By Drug Type, Through 2017
Figure 13 : Global Anticoagulant Drug Market By Drug Type, 2012
Figure 14 : Global Antiplatelet Market By Drug Type, 2017
Figure 15 : Total Global Antiplatelet Drug Market Competitive Analysis, 2012
Figure 16 : Projected Global Market Size And Growth By Region For Thrombin Inhibitors, 2011-2017
Figure 17 : Total Global Market For Thrombin Inhibitor Drug Revenues By Region, 2012
Figure 18 : Total Global Market For Thrombin Inhibitor Drug Revenues By Region, 2017
Figure 19 : Global Thrombin Inhibitor Market Revenue By Drug Type, 2011-2017
Figure 20 : Global Thrombin Inhibitor Market By Drug Type, 2012
Figure 21 : Global Thrombin Inhibitor Market By Drug Type, 2017
Figure 22 : Total Global Thrombin Inhibitor Drug Market Competitive Analysis, 2012
Figure 23 : Size Of Global Antithrombotic/Anticoagulant Market Revenue By Drug Type, 2011-2017
Figure 24 : Global Antithrombin/Anticoagulant Market By Drug Type, 2012
Figure 25 : Forecast Global Antithrombotic/Anticoagulant Market By Drug Type, 2017
Figure 26 : Global Market Size And Growth By Region For Antithrombotic/Anticoagulant Drugs, 2011-2017
Figure 27 : Global Antithrombotic/Anticoagulant Market By Geographic Region, 2012
Figure 28 : Global Antithrombotic/Anticoagulant Market By Drug Type, 2017
Figure 29 : Global Antithrombotic/Anticoagulant Drug Market Competitive Analysis, 2012

Browse more reports on the Pharmaceuticals Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals.

Explore newly published market research reports on other industries and for different geographies @ http://www.rnrmarketresearch.com/latest_reports.

About Us:

RnR Market Research is an online market research reports library of 175,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.

Contact:
Priyank Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales@rnrmarketresearch.com
Explore more Industry reports @ http://www.sandlerresearch.org/.

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.